ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P15502


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name ELN_HUMAN
Primary accession number P15502
Secondary accession numbers O15336 O15337 Q14233 Q14234 Q14235 Q14238 Q6P0L4 Q6ZWJ6 Q75MU5 Q7Z316 Q7Z3F5 Q9UMF5
Integrated into Swiss-Prot on April 1, 1990
Sequence was last modified on January 4, 2005 (Sequence version 2)
Annotations were last modified on    June 16, 2009 (Entry version 113)
Name and origin of the protein
Protein name Elastin [Precursor]
Synonym Tropoelastin
Gene name
Name: ELN
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3; 4 AND 6).
DOI=10.1073/pnas.84.16.5680; PubMed=3039501 [NCBI, ExPASy, EBI, Israel, Japan]
Indik Z., Yeh H., Ornstein-Goldstein N., Sheppard P., Anderson N., Rosenbloom J.C., Peltonen L., Rosenbloom J.;
"Alternative splicing of human elastin mRNA indicated by sequence analysis of cloned genomic and complementary DNA.";
Proc. Natl. Acad. Sci. U.S.A. 84:5680-5684(1987).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Skin fibroblast;
DOI=10.1111/1523-1747.ep12476591; PubMed=3171221 [NCBI, ExPASy, EBI, Israel, Japan]
Fazio M.J., Olsen D.R., Kauh E.A., Baldwin C.T., Indik Z., Ornstein-Goldstein N., Yeh H., Rosenbloom J., Uitto J.;
"Cloning of full-length elastin cDNAs from a human skin fibroblast recombinant cDNA library: further elucidation of alternative splicing utilizing exon-specific oligonucleotides.";
J. Invest. Dermatol. 91:458-464(1988).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 11).
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 7), AND VARIANT GLY-422.
TISSUE=Fetal kidney;
DOI=10.1186/1471-2164-8-399; PubMed=17974005 [NCBI, ExPASy, EBI, Israel, Japan]
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-422.
DOI=10.1038/nature01782; PubMed=12853948 [NCBI, ExPASy, EBI, Israel, Japan]
Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., Wilson R.K.;
"The DNA sequence of human chromosome 7.";
Nature 424:157-164(2003).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8), AND VARIANT ARG-610.
TISSUE=Eye;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
NUCLEOTIDE SEQUENCE OF 1-27.
PubMed=2722804 [NCBI, ExPASy, EBI, Israel, Japan]
Bashir M.M., Indik Z., Yeh H., Ornstein-Goldstein N., Rosenbloom J.C., Abrams W., Fazio M., Uitto J., Rosenbloom J.;
"Characterization of the complete human elastin gene. Delineation of unusual features in the 5'-flanking region.";
J. Biol. Chem. 264:8887-8891(1989).
[8]
NUCLEOTIDE SEQUENCE OF 1-27.
Bressan G.M.;
Submitted (JUN-1989) to the EMBL/GenBank/DDBJ databases.
[9]
SEQUENCE REVISION.
Bressan G.M.;
Submitted (OCT-1991) to the EMBL/GenBank/DDBJ databases.
[10]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-657 (ISOFORMS 9 AND 10), AND VARIANT ARG-610.
DOI=10.1093/hmg/6.7.1021; PubMed=9215670 [NCBI, ExPASy, EBI, Israel, Japan]
Li D.Y., Toland A.E., Boak B.B., Atkinson D.L., Ensing G.J., Morris C.A., Keating M.T.;
"Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis.";
Hum. Mol. Genet. 6:1021-1028(1997).
[11]
NUCLEOTIDE SEQUENCE [MRNA] OF 164-724 (ISOFORM 2).
TISSUE=Placenta;
PubMed=2831431 [NCBI, ExPASy, EBI, Israel, Japan]
Fazio M.J., Olsen D.R., Kuivaniemi H., Chu M.L., Davidson J.M., Rosenbloom J., Uitto J.;
"Isolation and characterization of human elastin cDNAs, and age-associated variation in elastin gene expression in cultured skin fibroblasts.";
Lab. Invest. 58:270-277(1988).
[12]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 500-786, AND TISSUE SPECIFICITY.
DOI=10.1006/geno.1996.0469; PubMed=8812460 [NCBI, ExPASy, EBI, Israel, Japan]
Osborne L.R., Martindale D.W., Scherer S.W., Shi X.-M., Huizenga J., Heng H.H.Q., Costa T., Pober B., Lew L., Brinkman J., Rommens J., Koop B.F., Tsui L.-C.;
"Identification of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients.";
Genomics 36:328-336(1996).
[13]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 659-786.
TISSUE=Hippocampus, and Placenta;
DOI=10.1016/S0092-8674(00)80077-X; PubMed=8689688 [NCBI, ExPASy, EBI, Israel, Japan]
Frangiskakis J.M., Ewart A.K., Morris C.A., Mervis C.B., Bertrand J., Robinson B.F., Klein B.P., Ensing G.J., Everett L.A., Green E.D., Proeschel C., Gutowski N.J., Noble M., Atkinson D.L., Odelberg S.J., Keating M.T.;
"LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition.";
Cell 86:59-69(1996).
[14]
INVOLVEMENT IN CUTIS LAXA.
DOI=10.1074/jbc.274.2.981; PubMed=9873040 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang M.-C., He L., Giro M., Yong S.L., Tiller G.E., Davidson J.M.;
"Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN).";
J. Biol. Chem. 274:981-986(1999).
[15]
INVOLVEMENT IN SVAS.
DOI=10.1007/s004390050028; PubMed=10942104 [NCBI, ExPASy, EBI, Israel, Japan]
Urban Z., Michels V.V., Thibodeau S.N., Davis E.C., Bonnefont J.-P., Munnich A., Eyskens B., Gewillig M., Devriendt K., Boyd C.D.;
"Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay.";
Hum. Genet. 106:577-588(2000).
[16]
HYDROXYLATION AT PRO-65; PRO-67; PRO-88; PRO-116; PRO-156; PRO-177; PRO-190; PRO-286; PRO-290; PRO-415; PRO-427; PRO-465; PRO-467; PRO-481; PRO-522; PRO-580; PRO-607; PRO-646; PRO-677; PRO-769 AND PRO-772, AND MASS SPECTROMETRY.
DOI=10.1016/j.chroma.2005.06.034; PubMed=16078697 [NCBI, ExPASy, EBI, Israel, Japan]
Schmelzer C.E.H., Getie M., Neubert R.H.H.;
"Mass spectrometric characterization of human skin elastin peptides produced by proteolytic digestion with pepsin and thermitase.";
J. Chromatogr. A 1083:120-126(2005).
[17]
HYDROXYLATION AT PRO-34; PRO-167; PRO-170; PRO-190; PRO-283; PRO-286; PRO-327; PRO-342; PRO-347; PRO-352; PRO-355; PRO-360; PRO-421; PRO-427; PRO-550; PRO-580; PRO-589; PRO-598 AND PRO-677, AND MASS SPECTROMETRY.
DOI=10.1002/prot.20643; PubMed=16161116 [NCBI, ExPASy, EBI, Israel, Japan]
Getie M., Schmelzer C.E.H., Neubert R.H.H.;
"Characterization of peptides resulting from digestion of human skin elastin with elastase.";
Proteins 61:649-657(2005).
Comments
  • FUNCTION: Major structural protein of tissues such as aorta and nuchal ligament, which must expand rapidly and recover completely. Molecular determinant of the late arterial morphogenesis, stabilizing arterial structure by regulating proliferation and organization of vascular smooth muscle (By similarity).
  • SUBUNIT: The polymeric elastin chains are cross-linked together into an extensible 3D network. Forms a ternary complex with BGN and MFAP2. Interacts with MFAP2 via divalent cations (calcium > magnesium > manganese) in a dose-dependent and saturating manner.
  • SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix. Note=Extracellular matrix of elastic fibers.
  • ALTERNATIVE PRODUCTS: 11 named isoforms [FASTA] produced by alternative splicing. Additional isoforms seem to exist.
    Name3
    Isoform IDP15502-3
    This is the isoform sequence displayed in this entry.
    Name1
    Isoform IDP15502-1
    Features which should be applied to build the isoform sequence: VSP_012484, VSP_012485, VSP_012487.
    Name2
    Isoform IDP15502-2
    Features which should be applied to build the isoform sequence: VSP_012484, VSP_012487.
    Name4
    Isoform IDP15502-4
    Features which should be applied to build the isoform sequence: VSP_012484.
    Name5
    Isoform IDP15502-5
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012481, VSP_012484, VSP_012487, VSP_012488.
    Name6
    Isoform IDP15502-6
    Features which should be applied to build the isoform sequence: VSP_012483, VSP_012487, VSP_012488.
    Name7
    Isoform IDP15502-7
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012479, VSP_012483, VSP_012487, VSP_012488.
    Name8
    Isoform IDP15502-8
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012482, VSP_012483, VSP_012486, VSP_012487, VSP_012488.
    Name9
    Isoform IDP15502-9
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012485.
    Name10
    Isoform IDP15502-10
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012485, VSP_012487.
    Name11
    Isoform IDP15502-11
    Note: No experimental confirmation available.
    Features which should be applied to build the isoform sequence: VSP_012480, VSP_012482, VSP_012483, VSP_012487, VSP_012488.
  • TISSUE SPECIFICITY: Expressed within the outer myometrial smooth muscle and throughout the arteriolar tree of uterus (at protein level). Also expressed in the large arteries, lung and skin.
  • PTM: Elastin is formed through the cross-linking of its soluble precursor tropoelastin. Cross-linking is initiated through the action of lysyl oxidase on exposed lysines to form allysine. Subsequent spontaneous condensation reactions with other allysine or unmodified lysine residues result in various bi-, tri-, and tetrafunctional cross-links. The most abundant cross-links in mature elastin fibers are lysinonorleucine, allysine aldol, desmosine, and isodesmosine.
  • PTM: Hydroxylation on proline residues within the sequence motif, GXPG, is most likely 4-hydroxy as this fits the requirement for 4-hydroxylation in vertebrates (By similarity).
  • DISEASE: Defects in ELN are a cause of autosomal dominant cutis laxa [MIM:123700]. Cutis laxa is a rare connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. The skin changes are often accompanied by extracutaneous manifestations, including pulmonary emphysema, bladder diverticula, pulmonary artery stenosis and pyloric stenosis.
  • DISEASE: Haploinsufficiency of ELN may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in Williams-Beuren syndrome (WBS) [MIM:194050]. WBS is a rare developmental disorder and a contiguous gene deletion syndrome involving genes from chromosome band 7q11.23.
  • DISEASE: Defects in ELN are the cause of supravalvular aortic stenosis (SVAS) [MIM:185500]. SVAS is a congenital narrowing of the ascending aorta which can occur sporadically, as an autosomal dominant condition, or as one component of Williams-Beuren syndrome.
  • SIMILARITY: Belongs to the elastin family.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=ELN";.
  • WEB RESOURCE: Name=Wikipedia; Note=Elastin entry; URL="http://en.wikipedia.org/wiki/Elastin";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M17282; AAC98393.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M16983; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17265; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17266; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17267; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17268; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17271; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17272; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17273; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17275; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17276; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17277; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17278; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17279; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17281; AAC98393.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17282; AAC98394.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M16983; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17265; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17266; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17267; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17268; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17270; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17271; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17272; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17273; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17275; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17276; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17277; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17278; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17279; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17280; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17281; AAC98394.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17282; AAC98395.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M16983; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17265; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17266; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17267; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17268; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17270; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17271; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17272; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17273; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17274; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17275; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17276; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17277; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17278; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17279; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17280; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M17281; AAC98395.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M36860; AAA52382.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK122731; BAC85506.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BX537939; CAD97910.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BX538199; CAD98065.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC005056; AAS07435.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC065566; AAH65566.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X15603; CAA33627.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93037; AAB65620.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93034; AAB65620.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93035; AAB65620.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93036; AAB65620.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93037; AAB65621.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93034; AAB65621.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93035; AAB65621.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U93036; AAB65621.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M24782; AAA53190.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U63721; AAC13884.1; ALT_INIT; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U62292; AAB17544.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00163202; -.
IPI00177942; -.
IPI00446835; -.
IPI00472548; -.
IPI00513726; -.
IPI00514114; -.
IPI00514196; -.
IPI00514508; -.
IPI00514851; -.
IPI00515021; -.
IPI00925620; -.
PIR A32707; EAHU.
RefSeq NP_001075221.1; -.
UniGene Hs.647061
3D structure databases
HSSP P50099; 1ZFJ. [HSSP ENTRY / PDB]
ModBase P15502.
PTM databases
PhosphoSite P15502; -.
Organism-specific databases
GeneCards GC07P073080; -.
H-InvDB HIX0006761; -.
HIX0019421; -.
HGNC HGNC:3327; ELN.
GenAtlas ELN.
HPA CAB010750; -.
HPA018111; -.
MIM 123700; phenotype. [NCBI / EBI]
130160; gene. [NCBI / EBI]
185500; phenotype. [NCBI / EBI]
194050; phenotype. [NCBI / EBI]
Orphanet 209; Cutis laxa.
90348; Cutis laxa, dominant type.
3193; Supravalvar aortic stenosis.
904; Williams syndrome.
PharmGKB PA27757; -.
Gene expression databases
ArrayExpress P15502; -.
Bgee P15502; -.
GermOnline ENSG00000049540; Homo sapiens.
Ontologies
GO
GO:0005615; Cellular component: extracellular space (inferred from electronic annotation from UniProtKB-SubCell).
GO:0005578; Cellular component: proteinaceous extracellular matrix (non-traceable author statement from UniProtKB).
GO:0030023; Molecular function: extracellular matrix constituent conferring elasticity (non-traceable author statement from UniProtKB).
GO:0008015; Biological process: blood circulation (traceable author statement from ProtInc).
GO:0008283; Biological process: cell proliferation (traceable author statement from ProtInc).
GO:0009887; Biological process: organ morphogenesis (traceable author statement from ProtInc).
GO:0007585; Biological process: respiratory gaseous exchange (traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR003979; Tropoelastin.
Graphical view of domain structure.
PRINTS PR01500; TROPOELASTIN.
Proteomic databases
PRIDE P15502; -.
Genome annotation databases
Ensembl ENSG00000049540; Homo sapiens. [Contig view]
GeneID 2006; -.
Phylogenomic databases
HOVERGEN P15502; -.
Other
DrugBank DB00533; Rofecoxib.
NextBio 8119; -.
PMAP-CutDB P15502; -.
SOURCE ELN; Homo sapiens.
ProtoNet P15502.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Alternative splicing; Disulfide bond; Extracellular matrix; Hydroxylation; Polymorphism; Repeat; Secreted; Signal; Williams-Beuren syndrome.
Features
SEVIEWER logo Feature table viewer
KeyFrom   To Length Description FTId
SIGNAL   1    26  26     By similarity. 
CHAIN   27   786  760     Elastin. PRO_0000021163
COMPBIAS   97   102  6     Poly-Ala. 
COMPBIAS   236   742  507     Ala-rich. 
MOD_RES   34    34        Hydroxyproline. 
MOD_RES   65    65        Hydroxyproline; partial. 
MOD_RES   67    67        Hydroxyproline; partial. 
MOD_RES   88    88        Hydroxyproline; partial. 
MOD_RES   104   104        Allysine (By similarity). 
MOD_RES   116   116        4-hydroxyproline; partial. 
MOD_RES   156   156        Hydroxyproline; partial. 
MOD_RES   167   167        Hydroxyproline; partial. 
MOD_RES   170   170        Hydroxyproline; partial. 
MOD_RES   177   177        Hydroxyproline; partial. 
MOD_RES   190   190        4-hydroxyproline; partial. 
MOD_RES   241   241        Allysine (By similarity). 
MOD_RES   261   261        Allysine (By similarity). 
MOD_RES   265   265        Allysine (By similarity). 
MOD_RES   283   283        4-hydroxyproline; partial. 
MOD_RES   286   286        4-hydroxyproline; partial. 
MOD_RES   290   290        Hydroxyproline; partial. 
MOD_RES   312   312        Allysine (By similarity). 
MOD_RES   315   315        Allysine (By similarity). 
MOD_RES   327   327        4-hydroxyproline; partial. 
MOD_RES   342   342        4-hydroxyproline; partial. 
MOD_RES   347   347        4-hydroxyproline; partial. 
MOD_RES   352   352        Hydroxyproline; partial. 
MOD_RES   355   355        Hydroxyproline; partial. 
MOD_RES   360   360        4-hydroxyproline; partial. 
MOD_RES   375   375        Allysine (By similarity). 
MOD_RES   379   379        Allysine (By similarity). 
MOD_RES   382   382        Allysine (By similarity). 
MOD_RES   415   415        4-hydroxyproline; partial. 
MOD_RES   421   421        Hydroxyproline; partial. 
MOD_RES   427   427        4-hydroxyproline; partial. 
MOD_RES   451   451        Allysine (By similarity). 
MOD_RES   465   465        Hydroxyproline; partial. 
MOD_RES   467   467        Hydroxyproline; partial. 
MOD_RES   481   481        4-hydroxyproline; partial. 
MOD_RES   492   492        Allysine (By similarity). 
MOD_RES   496   496        Allysine (By similarity). 
MOD_RES   522   522        Hydroxyproline; partial. 
MOD_RES   550   550        Hydroxyproline; partial. 
MOD_RES   558   558        Allysine (By similarity). 
MOD_RES   562   562        Allysine (By similarity). 
MOD_RES   566   566        Allysine (By similarity). 
MOD_RES   580   580        4-hydroxyproline; partial. 
MOD_RES   589   589        4-hydroxyproline (Probable). 
MOD_RES   598   598        4-hydroxyproline (Probable). 
MOD_RES   607   607        4-hydroxyproline; partial. 
MOD_RES   646   646        Hydroxyproline; partial. 
MOD_RES   653   653        Allysine (By similarity). 
MOD_RES   656   656        Allysine (By similarity). 
MOD_RES   677   677        4-hydroxyproline; partial. 
MOD_RES   693   693        Allysine (By similarity). 
MOD_RES   697   697        Allysine (By similarity). 
MOD_RES   735   735        Allysine (By similarity). 
MOD_RES   738   738        Allysine (By similarity). 
MOD_RES   769   769        Hydroxyproline; partial. 
MOD_RES   772   772        Hydroxyproline; partial. 
DISULFID   776   781        By similarity. 
VAR_SEQ   45    54        Missing (in isoform 7). VSP_012479
VAR_SEQ   78   180        Missing (in isoform 11). VSP_012480
VAR_SEQ   125   125        A -> AAPSVP (in isoform 5). VSP_012481
VAR_SEQ   215   228        Missing (in isoform 8 and isoform 11). VSP_012482
VAR_SEQ   453   500        Missing (in isoform 6, isoform 7, isoform 8 and isoform 11). VSP_012483
VAR_SEQ   453   481        Missing (in isoform 1, isoform 2, isoform 4 and isoform 5). VSP_012484
VAR_SEQ   500   500        F -> FALLNLA (in isoform 1, isoform 9 and isoform 10). VSP_012485
VAR_SEQ   555   570        AAAKSAAKVAAKAQLR -> G (in isoform 8). VSP_012486
VAR_SEQ   612   644        Missing (in isoform 1, isoform 2, isoform 5, isoform 6, isoform 7, isoform 8, isoform 10 and isoform 11). VSP_012487
VAR_SEQ   740   757        Missing (in isoform 5, isoform 6, isoform 7, isoform 8 and isoform 11). VSP_012488
VARIANT   422   422  1     S -> G (in dbSNP:rs2071307 [NCBI]). VAR_020882 
VARIANT   610   610  1     G -> R (in dbSNP:rs17855988 [NCBI]). VAR_056869 
CONFLICT   317   317        G -> E (in Ref. 4; CAD97910). 
CONFLICT   467   469        PQA -> APG (in Ref. 10; AAB65620/AAB65621). 
CONFLICT   553   553        V -> I (in Ref. 3; BAC85506). 
CONFLICT   691   691        A -> T (in Ref. 4; CAD98065). 
CONFLICT   773   773        G -> D (in Ref. 4; CAD97910). 
Sequence information
Length: 786 AA [This is the length of the unprocessed precursor] Molecular weight: 68499 Da [This is the MW of the unprocessed precursor] CRC64: 1E06FD2C692820F8 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG 

        70         80         90        100        110        120 
KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG 

       130        140        150        160        170        180 
LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP 

       190        200        210        220        230        240 
GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG 

       250        260        270        280        290        300 
KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT 

       310        320        330        340        350        360 
PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP 

       370        380        390        400        410        420 
GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV 

       430        440        450        460        470        480 
PSVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGAAGAGVL GGLVPGPQAA VPGVPGTGGV 

       490        500        510        520        530        540 
PGVGTPAAAA AKAAAKAAQF GLVPGVGVAP GVGVAPGVGV APGVGLAPGV GVAPGVGVAP 

       550        560        570        580        590        600 
GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG LGVGAGVPGL 

       610        620        630        640        650        660 
GVGAGVPGFG AGADEGVRRS LSPELREGDP SSSQHLPSTP SSPRVPGALA AAKAAKYGAA 

       670        680        690        700        710        720 
VPGVLGGLGA LGGVGIPGGV VGAGPAAAAA AAKAAAKAAQ FGLVGAAGLG GLGVGGLGVP 

       730        740        750        760        770        780 
GVGGLGGIPP AAAAKAAKYG AAGLGGVLGG AGQFPLGGVA ARPGFGLSPI FPGGACLGKA 


CGRKRK 

P15502 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!